Fig. 1From: Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cyclesComparisons of survival outcomes between the extended and standard chemotherapy groups. a Progression-free survival; b Overall survivalBack to article page